Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Alzheimer's Disease: A Real‑World Retrospective Cohort Study with Treatment Effect Heterogeneity Analysis - PubMe
3 hours ago
- #Mortality Risk
- #Alzheimer's Disease
- #Antipsychotics
- Aripiprazole is associated with significantly lower mortality than olanzapine and quetiapine in Alzheimer's disease patients.
- Quetiapine shows lower mortality compared to olanzapine and risperidone.
- Treatment effect heterogeneity exists, with aripiprazole being particularly protective in patients using type 2 diabetes mellitus medications.